120 related articles for article (PubMed ID: 26091800)
21. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
[TBL] [Abstract][Full Text] [Related]
23. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
[TBL] [Abstract][Full Text] [Related]
24. Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization.
Ray CE; Brown AC; Green TJ; Winston H; Curran C; Kreidler SM; Glueck DH; Rochon PJ
AJR Am J Roentgenol; 2015 Feb; 204(2):440-7. PubMed ID: 25615768
[TBL] [Abstract][Full Text] [Related]
25. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor.
Ishimaru H; Nakashima K; Sakugawa T; Sakamoto A; Matsuoka Y; Ashizawa K; Uetani M
AJR Am J Roentgenol; 2014 Apr; 202(4):744-51. PubMed ID: 24660701
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
Giacomoni A; Concone G; Di Sandro S; Lauterio A; De Carlis L
Transplantation; 2015 Sep; 99(9):e155-6. PubMed ID: 26308419
[No Abstract] [Full Text] [Related]
28. Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
Stampfl U; Bermejo JL; Sommer CM; Hoffmann K; Weiss KH; Schirmacher P; Schemmer P; Kauczor HU; Richter GM; Radeleff BA; Longerich T
J Vasc Interv Radiol; 2014 Jul; 25(7):1018-1026.e4. PubMed ID: 24768235
[TBL] [Abstract][Full Text] [Related]
29. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.
Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV
J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055
[TBL] [Abstract][Full Text] [Related]
31. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
[TBL] [Abstract][Full Text] [Related]
32. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.
Chen BB; Shih IL; Wu CH; Hsu C; Chen CH; Shih TT; Liu KL; Liang PC
J Vasc Interv Radiol; 2014 Mar; 25(3):371-8. PubMed ID: 24468045
[TBL] [Abstract][Full Text] [Related]
33. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
[TBL] [Abstract][Full Text] [Related]
34. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
35. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK
Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ;
J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
[TBL] [Abstract][Full Text] [Related]
37. The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas.
Choi TW; Kim HC; Lee JH; Yu SJ; Kang B; Hur S; Lee M; Jae HJ; Chung JW
Korean J Radiol; 2015; 16(6):1283-93. PubMed ID: 26576118
[TBL] [Abstract][Full Text] [Related]
38. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
Seehofer D; Nebrig M; Denecke T; Kroencke T; Weichert W; Stockmann M; Somasundaram R; Schott E; Puhl G; Neuhaus P
Clin Transplant; 2012; 26(5):764-74. PubMed ID: 22432589
[TBL] [Abstract][Full Text] [Related]
39. Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein.
Chung SR; Kim JH; Yoon HK; Ko GY; Gwon DI; Shin JH; Song HY; Ko HK; Yoon SM
J Vasc Interv Radiol; 2015 Aug; 26(8):1130-8. PubMed ID: 26119202
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone.
Cho YK; Chung JW; Ahn YS; Park YO; Kim JK; Byun JH
Korean J Radiol; 2006; 7(4):267-74. PubMed ID: 17143030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
